GT Biopharma Announces $3.2M Registered Direct Offering Of 740,000 Shares Of Common Stock At A Price Of $4.35 Per Share Under Nasdaq Rules
Portfolio Pulse from Benzinga Newsdesk
GT Biopharma has announced a $3.2 million registered direct offering priced at-the-market at $4.35 per share under Nasdaq rules.
May 21, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
GT Biopharma has announced a $3.2 million registered direct offering priced at-the-market at $4.35 per share under Nasdaq rules. This could lead to short-term volatility in the stock price.
The announcement of a direct offering often leads to a dilution of shares, which can result in a short-term decrease in stock price. The offering is priced at-the-market, which may cause immediate market reactions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100